Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » Life Science Insights Worldwide Therapeutic RNAi 2004-2014 Forecast and Analysis, Acuity Pharmaceuticals Cand5, and Mirus Online Store

Life Science Insights Worldwide Therapeutic RNAi 2004-2014 Forecast and Analysis, Acuity Pharmaceuticals Cand5, and Mirus Online Store

Oct 22, 2004
Premium

Life Science Insights said it has published “Worldwide Therapeutic RNAi 2004-2014 Forecast and Analysis,” an analysis of the RNAi-based drugs market.

According to the company, the report includes an overview of RNAi technologies and a 10-year market forecast.

“The RNAi therapeutic market will grow to over $10 billion by 2014 if the first few RNAi therapies are successful in human clinical trials, which will start later this year,” Life Science Insights senior research editor Zachary Zimmerman said in a statement released this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Plans Out

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

CovidNudge Numbers

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

Science Papers Propose Group to Discuss Genome-Editing Tools, Markers of Diabetes Drug Response, More

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Oct
28
Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

What's Popular?

In Gene Silencing/Gene Editing

  1. JumpCode Genomics Emerges From Stealth Mode With CRISPR-Based Library Prep Kits

    Premium

  2. Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable

    Premium

  3. CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

  4. Patent Board Rules Broad Institute First With Functioning CRISPR System in Eukaryotic Cells

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.